查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1378510

去细胞真皮基质市场：依来源、应用、地点和区域分类

Acellular Dermal Matrices Market, By Origin, By Application (Acute Wounds Chronic Wounds, and Reconstruction Procedures ), By Place of Setting (Hospitals, Ambulatory Surgical Centers, and Office Based), and By Region
出版日期: | 出版商: Coherent Market Insights | 英文 271 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2023 年，全球去细胞真皮基质市场规模将达到 88 亿美元，预测期内（2023-2030 年）年复合成长率为 12.1%。

报告范围 报告详情
基准年 2022年 2023年市场规模 88亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期年复合成长率 12.10% 2030年市场规模预测 196亿美元
图 1. 2023 年去细胞真皮基质的全球市场占有率(%)（按来源划分）
无细胞真皮基质市场-IMG1

去细胞真皮基质 (ADM) 是一种软结缔组织移植物，透过去细胞程序创建，使细胞外真皮基质保持完整。一旦植入体内，该结构将充当供体侧细胞的支架，促进未来的整合和再灌注。最初，去细胞真皮基质用于烧伤表面重建、腹壁修復、鼓膜置换、硬脑膜修復和牙龈移植。 ADM目前主要应用于乳房外科和整形外科。此外，去细胞真皮基质还可用于治疗急性伤口，如烧伤、外伤、癌症和感染疾病，以及慢性伤口，如糖尿病足溃疡、静脉性腿部溃疡和压疮。

市场动态

市场参与者正在致力于推出和核准用于重组等各种应用的新产品，预计这将在预测期内推动全球去细胞真皮基质市场的成长。例如，2023年5月，最大的人体组织供应商之一AlloSource推出了AlloMend Duo Acellular Dermal Matrix (ADM)，这是软组织重组的天然替代。 Aromend Duo ADM 的发展是为了帮助外科医生在修復和重组软组织异常时确保长期结构稳定性。 Aromendo Duo ADM 的特性具有多种优势，使其适用于需要人体再生组织基质强度和生物相容性的各种健康治疗。这种同种异体移植物灵活且柔韧，可实现理想的操作和精确的植入。

本研究的主要特点

  • 该研究报告对全球去细胞真皮基质市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率(CAGR)。
  • 它还阐明了各个细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
  • 它根据公司亮点、产品系列、主要亮点、业绩和策略等参数，介绍了全球去细胞真皮基质市场的主要企业。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、产品升级、市场扩张和行销策略做出资讯的决策。
  • 全球脱细胞真皮基质市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球去细胞真皮基质市场的各种策略矩阵，将促进相关人员的决策。

目录

第1章调查目的和假设

  • 这项研究的目的
  • 假设
  • 简称

第2章市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第3章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 最近的趋势
  • 主要进展
  • 法规场景
  • PEST分析
  • 波特的分析
  • 产品发布/核准合併、收购和合作

第4章全球去细胞真皮基质市场-新型冠状病毒感染疾病（COVID-19）的影响分析

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 对医疗保健产业的整体影响
  • COVID-19 疾病对全球去细胞真皮基质市场的整体影响
  • 供需分析

第5章全球去细胞真皮基质市场（依来源），2018-2030 年

  • 人类真皮
  • 猪真皮
  • 牛真皮

第6章全球去细胞真皮基质市场，依应用分类，2018-2030

  • 急性伤口
  • 烧伤
  • 瘢痕
  • 癌症
  • 感染疾病
  • 慢性伤口
  • 糖尿病足溃疡
  • 腿部静脉性溃疡
  • 压疮
  • 其他的
  • 重组程式
  • 腹壁手术
  • 乳房治疗
  • 整形外科手术
  • 其他的

第7章全球去细胞真皮基质市场（按地区划分），2018-2030 年

  • 医院
  • 住院病人
  • 门诊病人
  • 门诊手术中心
  • 办公室基地

第8章全球去细胞真皮基质市场，按地区，2018-2030

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 日本
  • 印度
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章竞争形势

  • 公司简介
    • Integra LifeSciences Corporation
    • AbbVie Inc.
    • Johnson &Johnson
    • HansBioMed
    • Becton, Dickinson and Company
    • Cook Group
    • Smith &Nephew Plc.
    • Reprise Biomedical
    • Organogenesis Holdings Inc.
    • Tissue Regenix
    • LifeNet Health
    • Zimmer Biomet Holdings, Inc.
    • Stryker Corporation
    • MiMedx Group
    • PolyNovo Limited
    • Fidia Pharma USA Inc.
    • Baxter International Inc.
    • In2Bones Global
    • BioHorizons, Inc.
    • Harbor MedTech, Inc.
    • MLM Biologics Inc.
    • Geistlich Pharma AG
    • Olaregen Therapeutix, Inc.
    • EnColl Corporation
    • Kerecis limited
    • DSM
    • ACell Inc.
    • 3M
    • Cell Constructs I, LLC
    • CG bio Inc.
    • Marine Polymer Technologies, Inc.
  • 分析师观点

第10章章

  • 调查方法
简介目录
Product Code: CMI4362

Global acellular dermal matrices market is estimated to be valued at US$ 8.8 Bn in 2023, and is expected to exhibit a CAGR of 12.1% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 8.8 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 12.10% 2030 Value Projection: US$ 19.6 Bn
Figure 1. Global Acellular Dermal Matrices Market Share (%), By Origin, 2023
Acellular Dermal Matrices Market - IMG1

Acellular dermal matrix (ADM) is a soft connective tissue graft created by a decellularization procedure that leaves the extracellular skin matrix intact. This structure, once implanted in the body, acts as a scaffold for donor-side cells, facilitating future integration and revascularization. Initially, acellular dermal matrices were employed in burn resurfacing, abdominal wall repair, tympanic membrane replacement, dural repairs, and gingival grafting. ADMs are now mostly employed in breast surgery and plastic surgery. Furthermore, acellular dermal matrices are used for treating acute wounds such as burns, traumatic wounds, cancer, and infections, as well as chronic wounds such as diabetic foot ulcers, venous leg ulcers, pressure ulcers, and others.

Market Dynamics

Market players are engaged in new product launches or approvals for various applications such as tissue reconstruction, and this is expected to drive the global acellular dermal matrices market growth over the forecast period. For instance, in May 2023, AlloSource, one of the largest human tissue providers, launched the AlloMend Duo Acellular Dermal Matrix (ADM), a natural alternative for soft tissue restoration. The AlloMend Duo ADM was developed to assist surgeons in the repair and reconstruction of soft tissue abnormalities for long-term structural stability. The deep reticular dermal allograft integrates with the surrounding tissue, and acts as scaffold for cell repopulation and regeneration of the native host tissues.

The properties of AlloMend Duo ADM provide several advantages, and this makes it suitable for use in a variety of health treatments that need the strength and biocompatibility of a human regenerating tissue matrix. The allograft is flexible and pliable, allowing for ideal handling and accurate implantation.

Key features of the study:

  • This report provides an in-depth analysis of the global acellular dermal matrices market and provides market size (US$ Bn) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global acellular dermal matrices market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Integra LifeSciences Corporation, AbbVie Inc., Johnson & Johnson, HansBioMed, Becton, Dickinson and Company, Cook Group, Smith & Nephew Plc., Reprise Biomedical, Organogenesis Holdings Inc., Tissue Regenix, LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation, MiMedx Group, PolyNovo Limited, Fidia Pharma USA Inc., Baxter International Inc., In2Bones Global, BioHorizons, Inc., Harbor MedTech, Inc., MLM Biologics Inc., Geistlich Pharma AG, Olaregen Therapeutix, Inc., EnColl Corporation, Kerecis limited, DSM, ACell Inc., 3M, Cell Constructs I, LLC, CG bio Inc., and Marine Polymer Technologies, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global acellular dermal matrices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global acellular dermal matrices market

Detailed Segmentation:

  • Global Acellular Dermal Matrices Market, By Origin:
    • Human Dermis
    • Porcine Dermis
    • Bovine Dermis
  • Global Acellular Dermal Matrices Market, By Application:
    • Acute Wounds
    • Burns
    • Trauma
    • Cancers
    • Infections
    • Chronic Wounds
    • Diabetic Foot Ulcers
    • Venous Leg Ulcers
    • Pressure Ulcer
    • Others
    • Reconstruction Procedures
    • Abdominal Wall Procedures
    • Breast Procedures
    • Orthopedic Procedures
    • Others
  • Global Acellular Dermal Matrices Market, By Place of Setting:
    • Hospitals
    • In- patient
    • Out- patient
    • Ambulatory Surgical Centers
    • Office Based
  • Global Acellular Dermal Matrices Market, By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • Integra LifeSciences Corporation
    • AbbVie Inc.
    • Johnson & Johnson
    • HansBioMed
    • Becton, Dickinson and Company
    • Cook Group
    • Smith & Nephew Plc.
    • Reprise Biomedical
    • Organogenesis Holdings Inc
    • Tissue Regenix
    • LifeNet Health
    • Zimmer Biomet Holdings, Inc.
    • Stryker Corporation
    • MiMedx Group
    • PolyNovo Limited
    • Fidia Pharma USA Inc.
    • Baxter International Inc.
    • In2Bones Global
    • BioHorizons, Inc.
    • Harbor MedTech, Inc.
    • MLM Biologics Inc.
    • Geistlich Pharma AG
    • Olaregen Therapeutix, Inc.
    • EnColl Corporation
    • Kerecis limited
    • DSM
    • ACell Inc.
    • 3M
    • Cell Constructs I, LLC
    • CG bio Inc.
    • Marine Polymer Technologies, Inc.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Origin
    • Market Snippet, By Application
    • Market Snippet, By Place of Setting
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Recent Trend
  • Key Developments
  • Regulatory Scenario
  • PEST Analysis
  • PORTER's Analysis
  • Product Launches/Approvals Mergers, Acquisitions and Collaborations

4. Global Acellular Dermal Matrices Market- COVID-19 Impact Analysis

  • COVID-19 Epidemiology
  • Overall Impact on Healthcare Sector
  • Total Impact of COVID-19 on Global Acellular Dermal Matrices Market
  • Supply and Demand Analysis

5. Global Acellular Dermal Matrices Market, By Origin, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • Human Dermis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 -2030, (US$ Bn)
  • Porcine Dermis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Bovine Dermis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Acellular Dermal Matrices Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • Acute Wounds
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Burns
  • Trauma
  • Cancers
  • Infections
  • Chronic Wounds
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Diabetic Foot Ulcers
  • Venous Leg Ulcers
  • Pressure Ulcer
  • Others
  • Reconstruction Procedures
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Abdominal Wall Procedures
  • Breast Procedures
  • Orthopedic Procedures
  • Others

7. Global Acellular Dermal Matrices Market, By Place of Setting, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • In- patient
  • Out- patient
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Office Based
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Acellular Dermal Matrices Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Place of Setting, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Place of Setting, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Place of Setting, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Place of Setting, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Place of Setting, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Place of Setting, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018 -2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Company Profiles
    • Integra LifeSciences Corporation
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • AbbVie Inc.
    • Johnson & Johnson
    • HansBioMed
    • Becton, Dickinson and Company
    • Cook Group
    • Smith & Nephew Plc.
    • Reprise Biomedical
    • Organogenesis Holdings Inc.
    • Tissue Regenix
    • LifeNet Health
    • Zimmer Biomet Holdings, Inc.
    • Stryker Corporation
    • MiMedx Group
    • PolyNovo Limited
    • Fidia Pharma USA Inc.
    • Baxter International Inc.
    • In2Bones Global
    • BioHorizons, Inc.
    • Harbor MedTech, Inc.
    • MLM Biologics Inc.
    • Geistlich Pharma AG
    • Olaregen Therapeutix, Inc.
    • EnColl Corporation
    • Kerecis limited
    • DSM
    • ACell Inc.
    • 3M
    • Cell Constructs I, LLC
    • CG bio Inc.
    • Marine Polymer Technologies, Inc.
  • Analysts' Views

10. Section

  • Research Methodology
  • About us and Sales Contact